Skip to main content

Table 5 Adverse events after GSMs-TACE treatment (n = 27)

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Adverse events Level 1 Level 2 Level 3 Level 4
Fever 15 5 1 0
Pain 13 2 1 0
Nausea and vomiting 7 2 1 0
Abscess 0 0 0 0
Cholecystitis 2 0 0 0
Pancreatitis 0 0 0 0
Renal insufficiency 1 0 0 0
Hepatic insufficiency 20 6 1 0
Bone marrow arrest 2 1 0 0